Skip to main content
. 2013 May 7;8(5):e63973. doi: 10.1371/journal.pone.0063973

Table 1. Baseline Characteristics by Sample: 2001–2005.

Unmatched Sample Conventional PS Matched TSPS Matched
Olanzapine (N = 7,082) Other SGAs (N = 13,544) Olanzapine (N = 6,829) Other SGAs (N = 6,829) Olanzapine (N = 6,777) Other SGAs (N = 6,777)
Age
Age at Index Fill Date – Means (SD) 42.3 (12.2) 41.8 (12.6) 42.2 (12.2) 42.0 (12.5) 42.1 (12.2) 42.2 (12.5)
18–29 17.9 19.9 18.3 19.1 18.3 18.6
30–39 21.5 21.2 21.4 21.6 21.5 21.9
40–49 30.1 28.6 30.9 29.0 30.0 28.3
50–64 30.5 30.3 30.2 30.3 30.2 31.2
Sex
Female 57.5 62.1 58.1 58.1 58.0 58.1
Race
White 46.2 51.7 47.5 47.5 47.9 47.9
Black 17.1 18.5 17.6 17.8 17.7 17.9
Hispanic 11.1 8.1 9.8 9.7 9.5 9.4
Other/Unknown 25.6 21.7 25.1 25.0 25.0 24.9
Medicaid Eligibility Category
Supplemental Security Income 65.4 64.8 65.9 65.8 66.1 66.1
Prior Health Services Utilization – Mean (SD)
Number of Outpatient Visits in Prior 6 Months 16.1 (21.2) 14.6 (18.4) 14.5 (18.5) 14.8 (18.7) 14.6 (18.5) 14.7 (18.9)
Number of Inpatient Visits in Prior 6 Months 1.8 (3.2) 2.0 (3.4) 1.8 (3.2) 1.8 (3.0) 1.8 (3.1) 1.8 (3.2)
Metabolic and Cardiovascular Risk Factors
Diabetes 8.5 11.5 8.7 8.9 8.7 8.8
Hyperlipidemia 9.3 9.6 9.0 9.2 8.8 8.4
Hypertension 23.9 27.4 24.0 23.4 23.9 23.9
Obesity 1.2 2.1 1.2 1.1 1.2 1.2
Peripheral Vascular Disease 2.2 1.6 1.9 1.7 1.6 1.8
Cerebrovascular Disease 3.0 2.9 2.9 2.8 3.0 2.9